Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by ReeferMadness38on Apr 16, 2024 9:16pm
59 Views
Post# 35992879

RE:RE:RE:RE:Senators Say Legal Sales Likely Won’t Happen Until

RE:RE:RE:RE:Senators Say Legal Sales Likely Won’t Happen Until

Rescheduling is a much better scenario for Tilray imo
This will allow them time to set up shop for eventual federal legslization in the US
Many don't realize the difference between a schedule 3 drug at the federal level and what is being sold as medical cannabis at the state level by MSOs
Getting an in-state cannabis license to go buy cannabis from a retail dispensary is not the same as prescription medication. A retail dispensary is not a pharmacy 
Most of these MSO companies are not GMP in medical and are heavily involved in recreational sales anyway.  They aren't going to be able to partner with legit pharma / medical companies like Tilray, who is completely set up to import immediately at a lower cost and also runs a legitimate legal US business already. Pharma / medical companies will be coming to Tilray and institutional investment will increase. Tilray is going after a different market  Tilray can also expand their medical cannabis operations into the US as they run a legit US business not selling rec weed. 

<< Previous
Bullboard Posts
Next >>